HSV-1 and Alzheimer’s disease: more than a hypothesis

Among the multiple factors concurring to Alzheimer’s disease (AD) pathogenesis, greater attention should be devoted to the role played by infectious agents. Growing epidemiological and experimental evidence suggests that recurrent herpes simplex virus type-1 (HSV-1) infection is a risk factor for AD although the underlying molecular and functional mechanisms have not been fully elucidated yet. Here, we review literature suggesting the involvement of HSV-1 infection in AD also briefly mentioning possible pharmacological implications of these findings.

[1]  J W DUGGAN,et al.  Herpes simplex virus. , 1961, Transactions of the Canadian Ophthalmological Society.

[2]  D. Pavan-Langston,et al.  Acylovir in oral and ganglionic herpes simplex virus infections. , 1979, The Journal of infectious diseases.

[3]  D. Pavan-Langston,et al.  Acyclovir in Oral and Ganglionic Herpes Simplex Virus Infections , 1979 .

[4]  M. Ball “Limbic Predilection in Alzheimer Dementia: Is Reactivated Herpesvirus Involved?” , 1982, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[5]  H Gordan,et al.  Herpes simplex. , 1982, International journal of dermatology.

[6]  P. Doherty,et al.  Central nervous system infection and immune response in mice inoculated into the lip with herpes simplex virus type 1 , 1982, Journal of Neuroimmunology.

[7]  A R Damasio,et al.  The limbic system and the localisation of herpes simplex encephalitis. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[8]  D. Selkoe,et al.  Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Selkoe,et al.  Microtubule-associated protein tau (? ) is a major antigenic component of paired helical filaments in Alzheimer disease , 1987 .

[10]  E. Lavi,et al.  Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome , 1988, Journal of virology.

[11]  N. A. Kefalides,et al.  Lithium chloride restores host protein synthesis in herpes simplex virus-infected endothelial cells. , 1989, Biochemical and biophysical research communications.

[12]  G. Wilcock,et al.  Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type , 1992, The Journal of pathology.

[13]  Mark P. Mattson,et al.  β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease , 1993, Trends in Neurosciences.

[14]  N. A. Kefalides,et al.  Lithium chloride suppresses the synthesis of messenger RNA for infected cell protein-4 and viral deoxyribonucleic acid polymerase in herpes simplex virus-1 infected endothelial cells. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[15]  J. Amsterdam,et al.  Suppression of Herpes Simplex Virus Infections with Oral Lithium Carbonate—A Possible Antiviral Activity , 1996, Pharmacotherapy.

[16]  R. Doms,et al.  Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells , 1997, Nature Medicine.

[17]  G. Wilcock,et al.  Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.

[18]  R. Itzhaki,et al.  Herpes simplex virus type I in brain and the type 4 allele of the apolipoprotein E gene are a combined risk factor for Alzheimer's disease. , 1998, Biochemical Society transactions.

[19]  J. Poirier,et al.  HSV-1 in brain and risk of Alzheimer's disease , 1998, The Lancet.

[20]  W. März,et al.  Apolipoprotein E Isoforms Increase Intracellular Ca2+ Differentially Through a ω‐Agatoxin IVa‐Sensitive Ca2+‐Channel , 1998, Brain pathology.

[21]  E. Mandelkow,et al.  Tau in Alzheimer's disease. , 1998, Trends in cell biology.

[22]  M. Wozniak,et al.  ApoE–viral interactions , 1998, Nature Medicine.

[23]  M. Tabaton,et al.  Alternative, Non-secretase Processing of Alzheimer’s β-Amyloid Precursor Protein during Apoptosis by Caspase-6 and -8* , 1999, The Journal of Biological Chemistry.

[24]  David Smith,et al.  Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation , 1999, Cell.

[25]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[26]  D. Small,et al.  Regulation of APP cleavage by α‐, β‐ and γ‐secretases , 2000 .

[27]  C. Cotman,et al.  Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide. , 2000, Biochemistry.

[28]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Cotman,et al.  Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to Alzheimer’ β amyloid peptide , 2000 .

[30]  J. Peter,et al.  Review of 3200 serially received CSF samples submitted for type-specific HSV detection by PCR in the reference laboratory setting. , 2001, Molecular and cellular probes.

[31]  G. Prince,et al.  Herpes simplex type 1 infects and establishes latency in the brain and trigeminal ganglia during primary infection of the lip in cotton rats and mice , 2002, Archives of Virology.

[32]  M. Bullido,et al.  Involvement of Apolipoprotein E in the Hematogenous Route of Herpes Simplex Virus Type 1 to the Central Nervous System , 2002, Journal of Virology.

[33]  C. Blake Amyloid Precursor Protein , 2002 .

[34]  L. Tsai,et al.  APP processing is regulated by cytoplasmic phosphorylation , 2003, The Journal of cell biology.

[35]  K. Hsu,et al.  Herpes simplex virus type 1 inoculation enhances hippocampal excitability and seizure susceptibility in mice , 2003, The European journal of neuroscience.

[36]  M. Bullido,et al.  ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1 , 2003, Neuroreport.

[37]  D. Bredesen,et al.  Caspase cleavage of the amyloid precursor protein modulates amyloid β‐protein toxicity , 2003, Journal of neurochemistry.

[38]  M. Mattson,et al.  Calcium orchestrates apoptosis , 2003, Nature Cell Biology.

[39]  M. Wozniak,et al.  Do infectious agents play a role in dementia? , 2003, Trends in microbiology.

[40]  F. LaFerla,et al.  Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau , 2004 .

[41]  A. Verier,et al.  Cognitive and psychiatric impairment in herpes simplex virus encephalitis suggest involvement of the amygdalo-frontal pathways , 1996, Journal of Neurology.

[42]  J. Friedman,et al.  A randomized clinical trial of valacyclovir in multiple sclerosis , 2005, Multiple sclerosis.

[43]  R. Itzhaki,et al.  Herpes simplex virus interferes with amyloid precursor protein processing , 2005, BMC Microbiology.

[44]  J. Alfaro,et al.  Herpes Simplex Virus Type 1 Infection via the Bloodstream with Apolipoprotein E Dependence in the Gonads Is Influenced by Gender , 2005, Journal of Virology.

[45]  M. Ball,et al.  Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of Herpes simplex virus type 1. , 2005, Medical hypotheses.

[46]  Hui Zheng,et al.  Molecular Neurodegeneration BioMed Central Review The amyloid precursor protein: beyond amyloid , 2006 .

[47]  J. Brion,et al.  Calcium-mediated Transient Phosphorylation of Tau and Amyloid Precursor Protein Followed by Intraneuronal Amyloid-β Accumulation* , 2006, Journal of Biological Chemistry.

[48]  Gopal Thinakaran,et al.  Amyloidogenic processing of β-amyloid precursor protein in intracellular compartments , 2006, Neurology.

[49]  J. Alfaro,et al.  Hematogenous Vertical Transmission of Herpes Simplex Virus Type 1 in Mice , 2006, Journal of Virology.

[50]  Y. Suh,et al.  Phosphorylation of Amyloid Precursor Protein (APP) at Thr668 Regulates the Nuclear Translocation of the APP Intracellular Domain and Induces Neurodegeneration , 2006, Molecular and Cellular Biology.

[51]  J. Burgos,et al.  Effect of Apolipoprotein E on the Cerebral Load of Latent Herpes Simplex Virus Type 1 DNA , 2006, Journal of Virology.

[52]  C. Almeida,et al.  Internalized Antibodies to the Aβ Domain of APP Reduce Neuronal Aβ and Protect against Synaptic Alterations*♦ , 2007, Journal of Biological Chemistry.

[53]  B. Ibach,et al.  Detection of Herpesvirus DNA in Cerebrospinal Fluid and Correlation with Clinical Symptoms , 2008, Infection.

[54]  M. Wozniak,et al.  Herpes simplex virus infection causes cellular β-amyloid accumulation and secretase upregulation , 2007, Neuroscience Letters.

[55]  P. Barberger‐Gateau,et al.  Seropositivity to Herpes Simplex Virus Antibodies and Risk of Alzheimer's Disease: A Population-Based Cohort Study , 2008, PloS one.

[56]  C. Carter Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: Relevance to pathological-signalling cascades , 2008, Neurochemistry International.

[57]  M. Wozniak,et al.  Susceptibility to herpes simplex labialis conferred by the gene encoding apolipoprotein E. , 2008, The Journal of infectious diseases.

[58]  C. Otth,et al.  Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. , 2008, Journal of Alzheimer's disease : JAD.

[59]  A. Palmeri,et al.  Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.

[60]  Y. Kawaguchi,et al.  Primary target cells of herpes simplex virus type 1 in the hippocampus. , 2008, Microbes and infection.

[61]  H. Fukuyama,et al.  Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease , 2008, Proceedings of the National Academy of Sciences.

[62]  C. Grassi,et al.  Role of methionine 35 in the intracellular Ca2+ homeostasis dysregulation and Ca2+‐dependent apoptosis induced by amyloid β‐peptide in human neuroblastoma IMR32 cells , 2008, Journal of neurochemistry.

[63]  F. Michetti,et al.  Dysregulation of intracellular calcium homeostasis is responsible for neuronal death in an experimental model of selective hippocampal degeneration induced by trimethyltin , 2008, Journal of neurochemistry.

[64]  D. Bredesen,et al.  Signal transduction in Alzheimer disease: p21‐activated kinase signaling requires C‐terminal cleavage of APP at Asp664 , 2008, Journal of neurochemistry.

[65]  L. Buée,et al.  Association of plasma amyloid β with risk of dementia , 2009, Neurology.

[66]  L. Buée,et al.  Association of plasma amyloid β with risk of dementia , 2009, Neurology.

[67]  Yuhai Zhao,et al.  HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling , 2009, Neuroreport.

[68]  M. Wozniak,et al.  Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1. , 2009, Journal of Alzheimer's disease : JAD.

[69]  K. Green Calcium in the initiation, progression and as an effector of Alzheimer’s disease pathology , 2009, Journal of cellular and molecular medicine.

[70]  D. Holtzman,et al.  The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.

[71]  MA Wozniak,et al.  Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques , 2009, The Journal of pathology.

[72]  E. Porcellini,et al.  Alzheimer's disease gene signature says: beware of brain viral infections , 2010, Immunity & Ageing.

[73]  R. Rubey Could lysine supplementation prevent Alzheimer’s dementia? A novel hypothesis , 2010, Neuropsychiatric disease and treatment.

[74]  A. Palamara,et al.  APP Processing Induced by Herpes Simplex Virus Type 1 (HSV-1) Yields Several APP Fragments in Human and Rat Neuronal Cells , 2010, PloS one.

[75]  Huaxi Xu,et al.  APP processing in Alzheimer's disease , 2011, Molecular Brain.

[76]  M. Weiner,et al.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.

[77]  E. Porcellini,et al.  Gene signature in Alzheimer's disease and environmental factors: the virus chronicle. , 2011, Journal of Alzheimer's disease : JAD.

[78]  P. Webster,et al.  Herpes Simplex Virus Dances with Amyloid Precursor Protein while Exiting the Cell , 2011, PloS one.

[79]  A. Palamara,et al.  HSV-1 promotes Ca2+-mediated APP phosphorylation and Aβ accumulation in rat cortical neurons , 2011, Neurobiology of Aging.

[80]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[81]  A. Palmeri,et al.  Endogenous amyloid‐β is necessary for hippocampal synaptic plasticity and memory , 2011, Annals of neurology.

[82]  Donald H. Lee,et al.  Herpes simplex encephalitis presenting with exclusively frontal lobe involvement , 2011, Journal of NeuroVirology.

[83]  L. Buée,et al.  Association between IgM Anti-Herpes Simplex Virus and Plasma Amyloid-Beta Levels , 2011, PloS one.

[84]  C. M. Preston,et al.  Antivirals Reduce the Formation of Key Alzheimer's Disease Molecules in Cell Cultures Acutely Infected with Herpes Simplex Virus Type 1 , 2011, PloS one.

[85]  G. Bitan,et al.  Surprising toxicity and assembly behaviour of amyloid β-protein oxidized to sulfone. , 2011, The Biochemical journal.

[86]  E. Posse de Chaves,et al.  Aβ Internalization by Neurons and Glia , 2011, International journal of Alzheimer's disease.

[87]  K. Vío,et al.  Tau cleavage at D421 by caspase-3 is induced in neurons and astrocytes infected with herpes simplex virus type 1. , 2011, Journal of Alzheimer's disease : JAD.

[88]  J. Richardson,et al.  Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease , 2012, PloS one.

[89]  E. Bearer HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships. , 2012, Future virology.

[90]  R. Schekman,et al.  Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans-Golgi network , 2012, Proceedings of the National Academy of Sciences.

[91]  C. Jack,et al.  Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study , 2012, The Lancet Neurology.

[92]  Daniel A Bórquez,et al.  The Amyloid Precursor Protein Intracellular Domain-Fe65 Multiprotein Complexes: A Challenge to the Amyloid Hypothesis for Alzheimer's Disease? , 2012, International journal of Alzheimer's disease.

[93]  O. Forlenza,et al.  Does Lithium Prevent Alzheimer’s Disease? , 2012, Drugs & Aging.

[94]  J. Richardson,et al.  Stabilizing ER Ca 2 + Channel Function as an Early Preventative Strategy for Alzheimer ’ s Disease , 2012 .

[95]  L. Mucke,et al.  Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. , 2012, Cold Spring Harbor perspectives in medicine.

[96]  Guojun Bu,et al.  Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[97]  D. Holtzman,et al.  Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide , 2012, The Journal of Neuroscience.

[98]  M. Wozniak,et al.  Could antivirals be used to treat Alzheimer's disease? , 2012, Future microbiology.

[99]  G. Bitan,et al.  Effects of different amyloid β-protein analogues on synaptic function , 2013, Neurobiology of Aging.

[100]  Shunichiro Shinagawa,et al.  Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease. , 2013, Biochemical and biophysical research communications.

[101]  N. Nalivaeva,et al.  From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein , 2013, Journal of neurochemistry.

[102]  J. Padmanabhan,et al.  Altered Processing of Amyloid Precursor Protein in Cells Undergoing Apoptosis , 2013, PloS one.

[103]  H. Buck,et al.  Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease. , 2013, Current Alzheimer research.

[104]  Hilmar Bading,et al.  Nuclear calcium signalling in the regulation of brain function , 2013, Nature Reviews Neuroscience.

[105]  A. Shah,et al.  ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions , 2013, Proceedings of the National Academy of Sciences.

[106]  E. Calabrese,et al.  Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[107]  R. Whitley,et al.  Herpes simplex virus. , 2014, Handbook of clinical neurology.

[108]  H. Soininen,et al.  Future directions in Alzheimer's disease from risk factors to prevention. , 2014, Biochemical pharmacology.

[109]  D. Butterfield,et al.  Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets. , 2014, Biochemical pharmacology.

[110]  K. Vío,et al.  Inflammatory and neurodegeneration markers during asymptomatic HSV-1 reactivation. , 2014, Journal of Alzheimer's disease : JAD.

[111]  M. Pardo,et al.  Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments. , 2014, Pharmacology & therapeutics.